Recent Finacing
Recent Raise
Avidity Biosciences develops Antibody‑Oligonucleotide Conjugates that use monoclonal antibodies to deliver oligonucleotide therapeutics to skeletal muscle, heart, and immune cells, advancing programs for rare muscle disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
